Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v9-FR Version v8-EN
Language French English
Date Updated 2022-07-20 2022-07-20
Drug Identification Number 02321114 02321114
Brand name LOTEMAX LOTEMAX
Common or Proper name LOTEMAX LOTEMAX
Company Name BAUSCH & LOMB INC BAUSCH & LOMB INC
Ingredients LOTEPREDNOL ETABONATE LOTEPREDNOL ETABONATE
Strength(s) 0.5% 0.5%
Dosage form(s) SUSPENSION SUSPENSION
Route of administration OPHTHALMIC OPHTHALMIC OPHTHALMIC OPHTHALMIC
Packaging size 10ml 10ml
ATC code S01BA S01BA
ATC description ANTIINFLAMMATORY AGENTS ANTIINFLAMMATORY AGENTS
Reason for shortage Delay in shipping of the drug. Delay in shipping of the drug.
Anticipated start date
Actual start date 2022-06-06 2022-06-06
Estimated end date 2022-07-10 2022-07-10
Actual end date 2022-07-10 2022-07-10
Shortage status Resolved Resolved
Tier 3 Status No No
Company comments
Health Canada comments